EyePoint EYPT
NASDAQ EYPT
$4.58 +0.01 (+0.33%)
As of: Sep 4, 2026 · 3:59 PM EDT

EyePoint (EYPT) Receivables - Net (2011 - 2026)

EyePoint (EYPT) posted Receivables - Net of $1.2 million for Q1 2026, up 77.73% sequentially from $651000.0 in Q4 2025, and up 161.76% YoY from $442000.0 in Q1 2025.

Analysis

EyePoint (EYPT) Receivables - Net (2011 - 2026) Analysis & Trends

EyePoint has reported Receivables - Net for 16 years, with the latest figure at $1.2 million in Q1 2026.

  • Quarterly Receivables - Net rose 161.76% year-over-year to $1.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.2 million (up 161.76% YoY) and the FY2025 annual result came in at $651000.0, up 7.25% from the prior year.
  • Receivables - Net advanced to $1.2 million in Q1 2026 per EYPT's latest filing, from $651000.0 in the prior quarter.
  • Over five years, Receivables - Net peaked at $22.6 million in Q2 2022 and troughed at $378000.0 in Q3 2024.
  • A 5-year average of $6.5 million and a median of $1.2 million in 2026 frame the typical range for Receivables - Net.
  • The sharpest annual moves came in 2023 and 2025: Receivables - Net slumped 97.69% in 2023, then soared 176.46% in 2025.
  • Over 5 years, Receivables - Net stood at $15.5 million in 2022, then sank by 94.81% to $805000.0 in 2023, then decreased by 24.6% to $607000.0 in 2024, then gained by 7.25% to $651000.0 in 2025, then jumped by 77.73% to $1.2 million in 2026.
  • According to Business Quant data, Receivables - Net over the past three periods registered $1.2 million, $651000.0, and $1.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 EyePoint 398.53 Mn 218.06 Mn 507,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 86,000.00
Mar 31, 2026 1.16 Mn
Dec 31, 2025 651,000.00
Sep 30, 2025 1.05 Mn
Jun 30, 2025 625,000.00
Mar 31, 2025 442,000.00
Dec 31, 2024 607,000.00
Sep 30, 2024 378,000.00
Jun 30, 2024 1.38 Mn
Mar 31, 2024 3.02 Mn
Dec 31, 2023 805,000.00
Sep 30, 2023 483,000.00
Jun 30, 2023 10.95 Mn
Mar 31, 2023 10.42 Mn
Dec 31, 2022 15.50 Mn
Sep 30, 2022 20.88 Mn
Jun 30, 2022 22.59 Mn
Mar 31, 2022 19.59 Mn
Dec 31, 2021 18.35 Mn
Sep 30, 2021 13.60 Mn